Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family
暂无分享,去创建一个
Takashi Suda | S. Nagata | P. Golstein | Tomohiro Takahashi | T. Suda | Shigekazu Nagata | Tomohiro Takahashi | Pierre Golstein
[1] P. Golstein,et al. Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity , 1993, The Journal of experimental medicine.
[2] S. Nagata,et al. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[3] P. Corthésy,et al. Hybrids between rat lymphoma and mouse T cells with inducible cytolytic activity , 1982, Nature.
[4] N. Copeland,et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.
[5] E. Clark,et al. Molecular and biological characterization of a murine ligand for CD40 , 1992, Nature.
[6] D. Hoessli,et al. Immunodetection of biotinylated lymphocyte-surface proteins by enhanced chemiluminescence: a nonradioactive method for cell-surface protein analysis. , 1992, Analytical biochemistry.
[7] S. Ju. Distinct pathways of CD4 and CD8 cells induce rapid target DNA fragmentation. , 1991, Journal of immunology.
[8] F. Ramsdell,et al. Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. , 1990, Science.
[9] N. Copeland,et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF , 1993, Cell.
[10] S. Yonehara,et al. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor , 1989, The Journal of experimental medicine.
[11] J. Marshall,et al. Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules , 1990, The Journal of experimental medicine.
[12] E. Podack,et al. A central role of perforin in cytolysis? , 1991, Annual review of immunology.
[13] W. J. Dower,et al. High efficiency transformation of E. coli by high voltage electroporation , 1988, Nucleic Acids Res..
[14] S. Nagata,et al. Expression cloning of a receptor for murine granulocyte colony-stimulating factor , 1990, Cell.
[15] D. I. Stuart,et al. Structure of tumour necrosis factor , 1989, Nature.
[16] M. Kozak,et al. An analysis of vertebrate mRNA sequences: intimations of translational control , 1991, The Journal of cell biology.
[17] G. Sutherland,et al. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor , 1993, Cell.
[18] V. Fadok,et al. Apoptosis and programmed cell death in immunity. , 1992, Annual review of immunology.
[19] V. Kuchroo,et al. The cytotoxic process of CD4 Th1 clones. , 1992, Journal of immunology.
[20] Bharat B. Aggarwal,et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin , 1984, Nature.
[21] J. Kerr,et al. Patterns of cell death. , 1988, Methods and achievements in experimental pathology.
[22] S. Nagata,et al. Lethal effect of the anti-Fas antibody in mice , 1993, Nature.
[23] A. Wyllie,et al. Cell death: the significance of apoptosis. , 1980, International review of cytology.
[24] N. Copeland,et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. , 1992, Journal of immunology.
[25] R. Smith,et al. The active form of tumor necrosis factor is a trimer. , 1987, The Journal of biological chemistry.
[26] S R Sprang,et al. The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-A resolution. , 1992, The Journal of biological chemistry.
[27] R. Eisenberg,et al. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.
[28] P. Leder,et al. Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[29] D. Allan,et al. Spermatogonial apoptosis has three morphologically recognizable phases and shows no circadian rhythm during normal spermatogenesis in the rat , 1992, Cell proliferation.
[30] H. Horvitz,et al. Mechanisms and functions of cell death. , 1991, Annual review of cell biology.
[31] M. Sitkovsky,et al. Cell-mediated cytotoxicity: contact and secreted factors. , 1993, Current opinion in immunology.
[32] R. Ueda,et al. Recombinant human-mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen. , 1987, Cancer research.
[33] L. Gooding,et al. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact , 1990, Cell.
[34] Atsushi Hase,et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.
[35] D. Banner,et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation , 1993, Cell.
[36] Carl F. Ware,et al. Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface , 1993, Cell.
[37] J. Sedivy. New Genetic Methods for Mammalian Cells , 1988, Bio/Technology.
[38] H. Tabuchi,et al. Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity. , 1991, The Journal of biological chemistry.
[39] M. Rudnicki,et al. Simplified mammalian DNA isolation procedure. , 1991, Nucleic acids research.
[40] M. Raff,et al. Social controls on cell survival and cell death , 1992, Nature.
[41] Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. , 1992, The Journal of biological chemistry.
[42] P. Möller,et al. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. , 1992, Journal of immunology.
[43] B. Beutler,et al. Cachectin and tumour necrosis factor as two sides of the same biological coin , 1986, Nature.
[44] J. D. Young,et al. Cell Death Mechanisms and the Immune System , 1991, Immunological reviews.
[45] S. Sprang,et al. The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding. , 1990, The Journal of biological chemistry.
[46] I. Stamenkovic,et al. CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.
[47] J. Mountz,et al. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse. , 1993, Journal of immunology.
[48] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[49] L. Old. Another chapter in the long history of endotoxin , 1987, Nature.
[50] C. Perez,et al. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF , 1988, Cell.
[51] A. Miyajima,et al. Expression cloning of a cDNA encoding the murine interleukin 4 receptor based on ligand binding. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[52] P. Möller,et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. , 1989, Science.
[53] S. Nagata,et al. Effect of bcl-2 on Fas antigen-mediated cell death. , 1993, Journal of immunology.
[54] S. Nagata,et al. Isolation and characterization of the human chromosomal gene for polypeptide chain elongation factor-1 alpha. , 1989, The Journal of biological chemistry.